Experiences with treatment of macular degeneration
Mewe, L.
Klinika Oczna 82(3): 153-155
1980
ISSN/ISBN: 0023-2157 PMID: 7190197 Document Number: 158961
Document emailed within 1 workday
Related Documents
Peyman, G.A.; Conway, M.D.; Recasens, M.A.; Peralta, E.; Kertes, P.J.; Greve, M.D.; El-Dessouky, E.S. 1999: Use of a macular buckle in the treatment of exudative age-related macular degeneration Ophthalmic Surgery and Lasers 30(8): 619-630Vojniković, B.; Vojniković, D. 2010: Benedictine monastery on the Island of Rab hides the mystery of sunlight influence on development of macular degeneration (AMD). Is a harmful sunlight, risk factor or cause of macular degeneration? Collegium Antropologicum 34(Suppl 2): 5-8
Seres, A.ás. 2004: Treatment of macular degeneration Orvosi Hetilap 145(26): 1381-1382
Kubicka-Trzaska, A.; Filemonowicz-Skoczek, A.; Karska-Basta, I.; Romanowska-Dixon, B. 2008: Exudative age-related macular degeneration or Best vitelliform macular dystrophy?--A case report Klinika Oczna 110(4-6): 183-187
Jalkh, A.E.; Kozłowski, J.M.; Kałuzny, J.; Trempe, C.L. 1985: Laser photocoagulation of the avascular macular area in senile macular degeneration Klinika Oczna 87(6): 233-235
Yuzawa, M.; Hagita, K.; Egawa, T.; Minato, H.; Matsui, M. 1991: Macular lesions predisposing to senile disciform macular degeneration Japanese Journal of Ophthalmology 35(1): 87-95
Haddad, W.M.; Souied, E.; Coscas, G.; Soubrane, G. 2006: Macular pigment and age-related macular degeneration. Clinical implications Bulletin de la Societe Belge d'Ophtalmologie 301: 15-22
Okada, A.A. 2002: Advances in the treatment of macular degeneration Nippon Ganka Gakkai Zasshi 106(10): 613-614
Chrapek, O.; Jirková, B.; Sín, M.; Fric, E.; Rehák, J. 2008: Modern treatment of wet-type macular degeneration Ceska a Slovenska Oftalmologie: Casopis Ceske Oftalmologicke Spolecnosti a Slovenske Oftalmologicke Spolecnosti 64(6): 249-251
Levitan, M.; Gombos, G.M.; Levitan, H.; Levitan, L.J. 1985: Senile macular degeneration and Kuhnt-Junius degeneration as separate entities: review Mount Sinai Journal of Medicine new York 52(8): 663-666
Tommila, P. 2005: Results of age related macular degeneration treatment improved Duodecim; Laaketieteellinen Aikakauskirja 121(8): 809-810
Dimofte, D.; Danielescu, C.; Chiseliţă, D. 2010: Treatment with bevacizumab in exudative age-related macular degeneration Oftalmologia 54(2): 116-122
Bloch, S.Brandi.; Larsen, M.; Haamann, P.; La Cour, M. 2008: New treatment of age-related macular degeneration. The Danish Society of Ophthalmology Ugeskrift for laeger 170(12): 1048
Budzinskaia, M.V.; Pogoda, T.V.; Generozov, E.V.; Chikun, E.A.; Gurova, I.V.; Shchegoleva, I.V.; Sizova, M.V. 2013: Contemporary pharmacogenetic approaches to the treatment of age-related macular degeneration Vestnik Oftalmologii 129(5): 128-135
Chowers, I.; Pe'er, J.; Tochner, Z.; Hemo, I.; Merin, S. 1999: Radiotherapy for the treatment of choroidal neovascularization secondary to age-related macular degeneration Harefuah 136(11): 877-880
Wiggins, M.N.; Uwaydat, S.H. 2006: Age-related macular degeneration: options for earlier detection and improved treatment Journal of Family Practice 55(1): 22-27
Muzyka-Woźniak, M.; Oficjalska-Młyńczak, J.; Gołebiowska, B. 2008: Safety and efficacy of using bevacizumab in the treatment of exudative age-related macular degeneration Klinika Oczna 110(7-9): 280-286
Molnárová, M.; Lesková, V.; Demský, P.; Vida, R.; Izák, M. 2009: Lucentis in treatment of the wet-form of age-related macular degeneration--two years experience Ceska a Slovenska Oftalmologie: Casopis Ceske Oftalmologicke Spolecnosti a Slovenske Oftalmologicke Spolecnosti 65(5): 182-185
Korda, V.; Hejcmanová, D.; Rencová, E.; Studnicka, J.; Odrázka, K. 2005: The results of radiotherapy 24 months after treatment by patients with age-related macular degeneration Ceska a Slovenska Oftalmologie: Casopis Ceske Oftalmologicke Spolecnosti a Slovenske Oftalmologicke Spolecnosti 61(3): 166-171
Papavasileiou, E.; Zygoura, V.; Richardson, T.; Cortis, D.; Eleftheriadis, H.; Jackson, T.L. 2015: Intravitreal aflibercept (A-IVI) for the treatment of neovascular age-related macular degeneration (nv-AMD): one year experience Hellenic Journal of Nuclear Medicine 18(Suppl 1): 29-32